United States securities and exchange commission logo

                 February 5, 2021

       Matthew T. Plavan
       President and Chief Executive Officer
       Arcadia Biosciences, Inc.
       202 Cousteau Place, Suite 105
       Davis, CA 95618

                                                        Re: Arcadia
Biosciences, Inc.
Statement on Form S-3
                                                            Filed February 2,
                                                            File No. 333-252659

       Dear Mr. Plavan:

              This is to advise you that we have not reviewed and will not
review your registration

               Please refer to Rules 460 and 461 regarding requests for
acceleration. We remind you
       that the company and its management are responsible for the accuracy and
adequacy of their
       disclosures, notwithstanding any review, comments, action or absence of
action by the staff.

              Please contact Jordan Metoyer at 202-551-6001 or Tim Buchmiller
at 202-551-3635 with
       any questions.


                 Division of Corporation Finance

                 Office of Life Sciences
       cc:                                              Michael De Angelis,